Physician profile
Guan Wu
NPI 1477590222
$5,337.01
in general payments reported to CMS, 2019-2025
9 companies · $25.70 in 2025
The $25.70 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,987 · 2020: $13.94 · 2021: $180 · 2023: $99.00 · 2024: $31.28 · 2025: $25.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $155.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,956.77 | 2019 | |
| Astellas Pharma US INC | $235.50 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $43.79 | 2024-2025 | Keytruda |
| Rochester Medical Corporation | $29.51 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $16.09 | 2019 | |
| Biotissue Holdings INC. | $15.12 | 2021 | |
| Amniox Medical, INC. | $13.94 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.19 | 2024 | Adstiladrin |
| Olympus America INC. | $13.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guan Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.